Pages that link to "Q34992520"
The following pages link to The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes (Q34992520):
Displaying 50 items.
- The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response (Q26995782) (← links)
- Middle East respiratory syndrome: obstacles and prospects for vaccine development (Q27013314) (← links)
- Drivers of Inter-individual Variation in Dengue Viral Load Dynamics (Q27882968) (← links)
- Identifying Candidate Targets of Immune Responses in Zika Virus Based on Homology to Epitopes in Other Flavivirus Species (Q28119651) (← links)
- Dengue: knowledge gaps, unmet needs, and research priorities (Q28729764) (← links)
- Patterns of cellular immunity associated with experimental infection with rDEN2Δ30 (Tonga/74) supports its suitability as a human DENV challenge strain (Q28729784) (← links)
- Human CD4+ T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection, in magnitude, HLA restriction and antigen specificity (Q28733418) (← links)
- Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells (Q28950660) (← links)
- In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination (Q30250977) (← links)
- CD4+ and CD8+ T-cell immunity to Dengue - lessons for the study of Zika virus (Q30394327) (← links)
- An Approach for a Synthetic CTL Vaccine Design against Zika Flavivirus Using Class I and Class II Epitopes Identified by Computer Modeling (Q33780548) (← links)
- CD8+ T lymphocyte expansion, proliferation and activation in dengue fever (Q35078921) (← links)
- Dengue Virus NS Proteins Inhibit RIG-I/MAVS Signaling by Blocking TBK1/IRF3 Phosphorylation: Dengue Virus Serotype 1 NS4A Is a Unique Interferon-Regulating Virulence Determinant (Q35620170) (← links)
- CD8+ T-cell Responses in Flavivirus-Naive Individuals Following Immunization with a Live-Attenuated Tetravalent Dengue Vaccine Candidate (Q36208591) (← links)
- Human CD8+ T-Cell Responses Against the 4 Dengue Virus Serotypes Are Associated With Distinct Patterns of Protein Targets (Q36250195) (← links)
- Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area. (Q36263779) (← links)
- Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine? (Q37115807) (← links)
- Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice (Q37137235) (← links)
- Licensed Dengue Vaccine: Public Health Conundrum and Scientific Challenge (Q37336555) (← links)
- Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection (Q37604714) (← links)
- Analysis of cell-mediated immune responses in support of dengue vaccine development efforts (Q38605194) (← links)
- Recent advances in dengue pathogenesis and clinical management (Q38605203) (← links)
- T cell immunity to dengue virus and implications for vaccine design. (Q38631171) (← links)
- Immune correlates of protection for dengue: State of the art and research agenda (Q38652971) (← links)
- A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone (Q38658737) (← links)
- Enhancing vaccine effectiveness with delivery technology (Q38765636) (← links)
- Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis model (Q38825543) (← links)
- Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen (Q38871575) (← links)
- A Tetravalent Formulation Based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and Monkeys. (Q39023333) (← links)
- Vaccines licensed and in clinical trials for the prevention of dengue (Q39172722) (← links)
- Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development (Q39535403) (← links)
- Development of Peptide Vaccines in Dengue. (Q40038715) (← links)
- Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections (Q40047603) (← links)
- Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Risks of Incomplete Immunity to Dengue Virus Revealed by Vaccination (Q40047862) (← links)
- Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? There Is Only One True Winner (Q40047872) (← links)
- The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model (Q40109446) (← links)
- Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans (Q41924182) (← links)
- How Can Elispot Add Information to Improve Knowledge on Tropical Diseases? (Q41928044) (← links)
- In silico design of a Zika virus non-structural protein 5 aiming vaccine protection against zika and dengue in different human populations (Q45324353) (← links)
- Plant-expressed Fc-fusion protein tetravalent dengue vaccine with inherent adjuvant properties. (Q47265866) (← links)
- Immune Response to Dengue and Zika (Q47551925) (← links)
- Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants (Q47558465) (← links)
- Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies (Q47562022) (← links)
- Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development. (Q51336680) (← links)
- Understanding dengue virus evolution to support epidemic surveillance and counter-measure development. (Q54226258) (← links)
- Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B. (Q55342452) (← links)
- Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone (Q56986149) (← links)
- Decreased accumulation of subgenomic RNA in human cells infected with vaccine candidate DEN4Δ30 increases viral susceptibility to type I interferon (Q57059015) (← links)
- Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus (Q57486493) (← links)
- Memory T Cells in Flavivirus Vaccination (Q57812953) (← links)